Ignite Creation Date:
2024-05-05 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00635817
Status:
COMPLETED
Last Update Posted:
2011-11-02
First Post:
2008-03-07
Brief Title:
A Study of Leuprolide 1125 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Sponsor:
Abbott
Organization:
Abbott
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Puberty Precocious |